Numerous studies have reported that AT-1R overexpression is potentially associated with various malignancies such as non-small cell lung cancer (14), gastric cancer (15,16), breast cancer (17,18), ovarian cancer (19), bladder cancer (20,21), pancreatic cancer (22,23) and prostate cancer (24–27). This evidence concerns the gene AGTR1 and breast carcinoma.